MARKET

ATRC

ATRC

AtriCure
NASDAQ

Real-time Quotes | Nasdaq Last Sale

33.59
+0.87
+2.66%
After Hours: 33.59 0 0.00% 16:00 03/31 EDT
OPEN
32.58
PREV CLOSE
32.72
HIGH
33.80
LOW
32.26
VOLUME
304.57K
TURNOVER
--
52 WEEK HIGH
44.51
52 WEEK LOW
22.57
MARKET CAP
1.35B
P/E (TTM)
-36.0756
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ATRC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ATRC stock price target is 48.83 with a high estimate of 52.00 and a low estimate of 42.00.

EPS

ATRC News

More
  • These Dayton stocks skyrocketed as market posts best day since 1933
  • American City Business Journals · 03/24 22:09
  • Here's how Dayton stocks fared as Dow falls to lowest level since 2016
  • American City Business Journals · 03/23 19:29
  • Dayton stocks tumble as Dow falls, ending 11-year bull run
  • American City Business Journals · 03/12 14:21
  • The Mechanics Of Fear: Prioritize Cash, Then Health, Cloud, Med-Tech And Social
  • Seeking Alpha - Article · 03/04 16:12

Industry

Medical Equipment, Supplies & Distribution
-0.22%
Healthcare Equipment & Supplies
-0.61%

Hot Stocks

Symbol
Price
%Change

About ATRC

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. It has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion. The Company also sells Lumitip dissectors and the Estech line of reusable cardiac surgery (valve) instruments. Its cryoICE cryosurgery product line offers various cryoablation devices. Its AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA).
More

Webull offers kinds of AtriCure Inc. stock information, including NASDAQ:ATRC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATRC stock news, and many more online research tools to help you make informed decisions.